TMDX logo

TMDX
Transmedics Group Inc

6,681
Mkt Cap
$5.08B
Volume
701,509.00
52W High
$156.00
52W Low
$62.07
PE Ratio
30.47
TMDX Fundamentals
Price
$147.66
Prev Close
$148.00
Open
$149.14
50D MA
$134.25
Beta
1.33
Avg. Volume
794,618.11
EPS (Annual)
$4.87
P/B
10.72
Rev/Employee
$674,269.49
$4,962.69
Loading...
Loading...
News
all
press releases
TransMedics Group, Inc. $TMDX Shares Acquired by DNB Asset Management AS
DNB Asset Management AS lifted its position in TransMedics Group, Inc. (NASDAQ:TMDX - Free Report) by 199.8% in the 3rd quarter, according to the company in its most recent 13F filing with the...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
TransMedics Group, Inc. $TMDX Shares Acquired by Citigroup Inc.
Citigroup Inc. boosted its holdings in TransMedics Group, Inc. (NASDAQ:TMDX - Free Report) by 29.3% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and...
MarketBeat·3d ago
News Placeholder
Wall Street Zen Downgrades TransMedics Group (NASDAQ:TMDX) to Hold
Wall Street Zen lowered TransMedics Group from a "buy" rating to a "hold" rating in a research note on Saturday...
MarketBeat·5d ago
News Placeholder
TransMedics Group (NASDAQ:TMDX) Shares Up 5.9% - What's Next?
TransMedics Group (NASDAQ:TMDX) Trading Up 5.9% - What's Next...
MarketBeat·5d ago
News Placeholder
Vanguard Group Inc. Buys 9,650 Shares of TransMedics Group, Inc. $TMDX
Vanguard Group Inc. raised its stake in TransMedics Group, Inc. (NASDAQ:TMDX - Free Report) by 0.3% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange...
MarketBeat·5d ago
News Placeholder
TransMedics Provides Additional Information on the Impact of the Release of the Valuation Allowance on Deferred Tax Assets on Previously Reported Fourth Quarter Financial Results
TransMedics Provides Additional Information on the Impact of the Release of the Valuation Allowance on Deferred Tax Assets on Previously Reported Fourth Quarter Financial Results TransMedics Provides...
PR Newswire·5d ago
News Placeholder
JPMorgan Chase & Co. Issues Positive Forecast for TransMedics Group (NASDAQ:TMDX) Stock Price
JPMorgan Chase & Co. lifted their price objective on shares of TransMedics Group from $114.00 to $149.00 and gave the stock a "neutral" rating in a research report on Wednesday...
MarketBeat·7d ago
News Placeholder
TransMedics Group (NASDAQ:TMDX) Stock Price Expected to Rise, Oppenheimer Analyst Says
Oppenheimer upped their price objective on TransMedics Group from $150.00 to $175.00 and gave the stock an "outperform" rating in a report on Wednesday...
MarketBeat·7d ago
News Placeholder
TMDX Stock Rises as Q4 Earnings & Revenues Beat Estimates
TransMedics posts 200% EPS surge and 32% revenue growth in Q4, tops estimates and guides for up to 25% sales growth in 2026.
Zacks·7d ago
News Placeholder
Piper Sandler Forecasts Strong Price Appreciation for TransMedics Group (NASDAQ:TMDX) Stock
Piper Sandler raised their target price on shares of TransMedics Group from $140.00 to $160.00 and gave the company an "overweight" rating in a research note on Wednesday...
MarketBeat·7d ago
<
1
2
...
>

Latest TMDX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.